This document provides an introduction to chemical pathology (clinical biochemistry). It discusses what chemical pathology is, the rational use of laboratory tests, and purposes of laboratory tests such as screening, diagnosis, monitoring treatment, and prognosis. It also covers sources of variation in test results, including analytical sources like precision and accuracy as well as biological sources like diurnal variation. Reference ranges are described as providing the expected range of results for healthy individuals. Key metrics for diagnostic tests like sensitivity and specificity are also introduced.
Chemical pathology involves the biochemical analysis of bodily fluids to aid in disease diagnosis and management. Dr. S.A. Sakyi's presentation outlines the scope and objectives of chemical pathology, which includes describing disease mechanisms, selecting appropriate tests, and specimen collection and handling. Key aspects covered include common tests performed in chemical pathology laboratories, the roles of chemical pathology in healthcare, and factors that can influence laboratory test results such as diet, medications, and specimen processing.
This document provides an introduction to chemical pathology, including:
1. Definitions of chemical pathology and its focus on describing biochemical changes in the body during health and disease.
2. An overview of the organization of chemical pathology departments and courses, including lectures, study materials, and clinical laboratory services.
3. Descriptions of common laboratory analysis methods like colorimetry, fluorimetry, immunoassays, electrophoresis, and chromatography.
4. Guidance on interpreting laboratory results, including evaluating the clinical context, units of measurement, and reference ranges.
This document provides an overview of quality control in clinical biochemistry laboratories. It discusses that quality control aims to ensure test results are correct by minimizing errors. Errors can occur in the pre-analytical, analytical, and post-analytical phases. The pre-analytical phase, involving sample collection and handling, accounts for most errors. Laboratories use internal quality control methods like calibration, controls, and Levey-Jennings charts daily, as well as external quality assurance programs, to monitor performance and identify errors. Maintaining quality control is important for generating accurate, reliable test results.
Automated cell counter & its quality controlSaikat Mandal
Automated hematology analyzers provide several advantages over manual methods including speed, accuracy, precision, and the ability to perform multiple tests on a single sample. They work using various principles such as electrical impedance, optical light scatter, and fluorescence to count and characterize red blood cells, white blood cells, and platelets. Quality control measures like the use of controls analyzed daily and the application of rules like the Westgard rules help monitor the performance of these automated analyzers.
This document provides an overview of clinical pathology techniques and examinations. It begins with acknowledgements and then outlines contents including sections on clinical pathology, seminal fluid analysis, hematology, clinical biochemistry, and urine analysis. Specific tests and procedures are described for urine examination including physical properties, chemical tests for sugar, protein, acetone and others. Microscopic findings in urine such as epithelial cells, casts, crystals and bacteria are also detailed.
these clearance test plays an very important role in determining the functioning capacity and working status of kidney.
and we estimate how amount of compund is excreted in the urine and absorption too.
and i also attached the mathematical caluculation to identify the metabolic valuve of urea, creatinine, inulin clearance by kidney.
The document discusses pre-analytical errors that can occur prior to laboratory testing and affect test results. It outlines various factors in the pre-analytical phase including proper patient identification, preparation, sample collection techniques, sample handling and processing, and stability of samples. Key areas that can introduce errors are identified as patient identification, order of tube draw, sample mixing and centrifugation, and stability of whole blood, serum and plasma samples. Standardizing procedures and monitoring pre-analytical variables is important for reliable test results and patient outcomes.
Use of laboratory instruments and specimen processing equipment to perform clinical laboratory assays with only minimal involvement of technologist .
Automation in clinical laboratory is a process by which analytical instruments perform many tests with the least involvement of an analyst.
The International Union of Pure and Applied Chemistry (IUPAC) define automation as "The replacement of human manipulative effort and facilities in the performance of a given process by mechanical and instrumental devices that are regulated by feedback of information so that an apparatus is self-monitoring or self adjusting”.
Chemical pathology involves the biochemical analysis of bodily fluids to aid in disease diagnosis and management. Dr. S.A. Sakyi's presentation outlines the scope and objectives of chemical pathology, which includes describing disease mechanisms, selecting appropriate tests, and specimen collection and handling. Key aspects covered include common tests performed in chemical pathology laboratories, the roles of chemical pathology in healthcare, and factors that can influence laboratory test results such as diet, medications, and specimen processing.
This document provides an introduction to chemical pathology, including:
1. Definitions of chemical pathology and its focus on describing biochemical changes in the body during health and disease.
2. An overview of the organization of chemical pathology departments and courses, including lectures, study materials, and clinical laboratory services.
3. Descriptions of common laboratory analysis methods like colorimetry, fluorimetry, immunoassays, electrophoresis, and chromatography.
4. Guidance on interpreting laboratory results, including evaluating the clinical context, units of measurement, and reference ranges.
This document provides an overview of quality control in clinical biochemistry laboratories. It discusses that quality control aims to ensure test results are correct by minimizing errors. Errors can occur in the pre-analytical, analytical, and post-analytical phases. The pre-analytical phase, involving sample collection and handling, accounts for most errors. Laboratories use internal quality control methods like calibration, controls, and Levey-Jennings charts daily, as well as external quality assurance programs, to monitor performance and identify errors. Maintaining quality control is important for generating accurate, reliable test results.
Automated cell counter & its quality controlSaikat Mandal
Automated hematology analyzers provide several advantages over manual methods including speed, accuracy, precision, and the ability to perform multiple tests on a single sample. They work using various principles such as electrical impedance, optical light scatter, and fluorescence to count and characterize red blood cells, white blood cells, and platelets. Quality control measures like the use of controls analyzed daily and the application of rules like the Westgard rules help monitor the performance of these automated analyzers.
This document provides an overview of clinical pathology techniques and examinations. It begins with acknowledgements and then outlines contents including sections on clinical pathology, seminal fluid analysis, hematology, clinical biochemistry, and urine analysis. Specific tests and procedures are described for urine examination including physical properties, chemical tests for sugar, protein, acetone and others. Microscopic findings in urine such as epithelial cells, casts, crystals and bacteria are also detailed.
these clearance test plays an very important role in determining the functioning capacity and working status of kidney.
and we estimate how amount of compund is excreted in the urine and absorption too.
and i also attached the mathematical caluculation to identify the metabolic valuve of urea, creatinine, inulin clearance by kidney.
The document discusses pre-analytical errors that can occur prior to laboratory testing and affect test results. It outlines various factors in the pre-analytical phase including proper patient identification, preparation, sample collection techniques, sample handling and processing, and stability of samples. Key areas that can introduce errors are identified as patient identification, order of tube draw, sample mixing and centrifugation, and stability of whole blood, serum and plasma samples. Standardizing procedures and monitoring pre-analytical variables is important for reliable test results and patient outcomes.
Use of laboratory instruments and specimen processing equipment to perform clinical laboratory assays with only minimal involvement of technologist .
Automation in clinical laboratory is a process by which analytical instruments perform many tests with the least involvement of an analyst.
The International Union of Pure and Applied Chemistry (IUPAC) define automation as "The replacement of human manipulative effort and facilities in the performance of a given process by mechanical and instrumental devices that are regulated by feedback of information so that an apparatus is self-monitoring or self adjusting”.
Analytical and post-analytical errors can occur in clinical chemistry laboratories. Analytical errors include issues like test systems not being calibrated properly, controls being out of range but results still reported, improper measurements or reagents, and instrument maintenance issues. This can lead to inaccuracies, imprecisions, insensitivities, and linearity problems. Post-analytical errors involve things like transcription mistakes in reporting results, reports going to the wrong location, illegible reports, or reports not being sent at all. Laboratories should develop systematic workflows, continuously monitor for errors, and strengthen defenses to minimize vulnerabilities and their impacts, which can include inadequate patient care, misdiagnosis, harm, or even death.
This document discusses quality control in pathology, with a focus on histopathology. It defines key terms like quality control, quality assurance, and defines the goals of a quality system. It outlines the quality assurance cycle and different factors that can influence quality, including pre-analytical, analytical, and post-analytical phases. Specific areas of quality control in histopathology are discussed, including sample collection and handling, tissue processing, section cutting, and staining. Maintaining standards and addressing errors at each step of the histopathology process is important for accurate diagnosis.
Venous blood collection, or venipuncture, allows for collection of large blood volumes from the median cubital vein in the antecubital fossa for numerous clinical tests. The procedure involves cleaning the site, applying a tourniquet, inserting a vacutainer needle to fill test tubes, removing the needle and applying pressure to stop bleeding. Proper collection permits complete blood counts, cell analyses, and other tests to aid clinical evaluation and diagnosis.
This document provides an overview of gastric analysis, which quantifies gastric acid production by the stomach. It discusses the anatomy and physiology of the stomach and acid secretion. Methods for collecting gastric juice samples via nasogastric tube are described, including basal acid output measurement and stimulation with pentagastrin to measure peak acid output. Normal ranges for acidity measurements and their indications are provided. The document outlines contraindications and alternative tests like Hollander's test and fractional test meal.
The document discusses various pre-analytical and post-analytical errors that can occur in clinical laboratories. It notes that errors commonly occur in specimen receiving, sampling, transport, and results reporting. Some common errors include entering the wrong patient data, incomplete patient information, misidentifying tests, collecting samples from patients with the wrong test orders, and not fulfilling all requested investigations. The document also discusses various biological and environmental factors that can influence laboratory test results, such as patient posture, exercise, underlying medical conditions, drug use, and diet. Proper specimen collection and handling is important to avoid pre-analytical errors.
The peritoneal fluid analysis helps diagnose the cause of fluid accumulation in the abdominal cavity. The fluid is either a transudate or exudate based on initial tests of albumin level and cell count. A transudate is usually caused by heart or liver conditions, while an exudate requires further testing to identify potential infections, cancers, or other inflammatory conditions as the cause. Additional tests of the exudate fluid include microscopic analysis of cell types, chemical tests for glucose or tumor markers, and cultures to detect microorganisms. The results help determine whether the fluid accumulation is due to an infection, malignancy, or other disease.
This document discusses laboratory errors in medical practice. It notes that 0.1-3% of laboratory tests have errors, with most occurring in the pre-analytic and post-analytic phases rather than the analytic phase. Common pre-analytic errors include inappropriate test requests, order entry mistakes, misidentification of patients, and improper sample collection, transport, or storage. Analytic errors are less than 10% of total errors. The document also provides examples of how biological and behavioral factors can influence test results, and discusses clinical performance characteristics of medical tests.
This document discusses external quality assurance (EQA) of serological testing. It outlines key elements of a quality system including documentation, training, assessment, and standards. EQA involves laboratories testing unknown samples provided by an EQA scheme and comparing results to improve accuracy. Participating in EQA allows laboratories to identify any issues, enhance performance, and ensure quality standards are met through objective review of results across laboratories. EQA schemes provide benefits for laboratories and regulatory authorities by establishing networks to improve testing practices and public confidence in testing standards.
This chapter is largely about the water and electrolytes ( salts )in your plasma and how the body manages to keep you from drying up and blowing away even if you are in the hot Texas sun and without liquid drink.
This document discusses the uses and types of clinical biochemistry investigations as well as quality control procedures. It notes that lab tests are used to confirm diagnoses, start treatment, screen for risk, monitor disease progression and response to therapy. Tests can be emergency, routine, special, or panels focusing on specific organs or metabolic processes. Quality control ensures accuracy, precision and error-free reporting through procedures like internal controls, reference ranges, and external quality assessments. Factors like specimen collection, transport, drugs, and physiology can influence test results.
This document provides an overview of the analysis of various body fluids, including pleural, pericardial, peritoneal, synovial, and ascitic fluids. It discusses the sample collection, gross inspection, and microscopic analysis of these fluids. Key points covered include diagnostic tests for identifying conditions like pleurisy, pericarditis, tuberculous peritonitis, gout, and arthritis. Procedures like thoracentesis, paracentesis, arthrocentesis, and pericardiocentesis used to collect fluid samples are also outlined. The learning objectives are to recall sample collection and analysis of these body fluids and become familiar with related chemical, immunological, microbiological and functional tests.
Biochemistry is a basic science which deals with chemical nature and chemical behaviour of living matter and with the reactions and processes they undergo.
Biochemistry involves the study of:
Chemical constituents of living matter.
Chemical changes which occur in the organism during digestion, absorption and excretion.
Chemical changes which occur during growth and multiplication of the organism.
Transformation of one form of chemical constituent to the other.
Energy changes involved in such transformation.
Note:- The term “Biochemistry” was first introduced by German chemist Carl Neuberg in 1903 from Greek word “bios” means “life”.
It is mainly deals with the biochemical aspects that are involved in several conditions.
The results of qualitative and quantitative analysis of body fluids assist the clinicians in the diagnosis, treatment and prevention of the disease and drug monitoring, tissue and organ transplantation, forensic investigations and so on.
Various biological fluids subjected to chemical tests and assays include blood, plasma, serum, urine, cerebrospinal fluid (CSF), ascetic fluid, pleural fluid, faeces, calculi and tissues.
Note:- Modern day medical practice is highly dependent on the laboratory analysis of body fluids, especially the blood. The disease manifestations are reflected in the composition of blood and other tissues.
Hence, the demarcation of abnormal from normal constituents of the body is another aim of the study of clinical biochemistry.
This document summarizes renal clearance tests used to assess kidney function. It discusses how the kidneys maintain homeostasis, excrete waste, and produce hormones. Glomerular filtration rate is normally 120-125 mL/min, with over 99% of the filtrate reabsorbed. Clearance tests measure the rate of filtration for substances like creatinine and urea. Creatinine clearance is the most sensitive test of glomerular function, as creatinine is freely filtered and only marginally secreted. The normal creatinine clearance rate is 120-145 mL/min. A decreased clearance below 75% normal indicates impaired kidney function.
This document provides information about urinalysis, including specimen collection, types of analysis, and microscopic examination. Specimens should be first morning void and analyzed within 2 hours of collection. Types of analysis include macroscopic examination of color, odor, and turbidity; chemical analysis using urine dipstick for glucose, bilirubin, ketones, specific gravity, blood, pH, protein, urobilinogen, nitrite, and leukocyte esterase; and microscopic examination of cells, casts, crystals, and microorganisms. Abnormal findings on microscopic examination include increased red and white blood cells, epithelial cells, bacteria, fungi, and pathological crystals.
Pre analytic and postanalytic test managementVarsha Shahane
The document discusses principles of pre-analytic, analytic, and post-analytic test management. It covers test selection and evaluation, requisition and test menu formats, and report formatting. The three phases of quality assurance - pre-analytic, analytic, and post-analytic - are described in detail, including factors influencing each phase like specimen handling, equipment calibration, and report review. Quality control procedures are also outlined to ensure test accuracy and reproducibility.
diagnostic Cytology introduction , Body fluids cytologyAayra
This document discusses diagnostic cytopathology. It covers:
1. Cytopathology examines cells from body cavities, mucosal surfaces, and organs/masses obtained via needle aspiration to determine the cause of disease microscopically.
2. The history of cytopathology including the contributions of Papanicolaou and Koss.
3. The advantages of cytopathology include rapid diagnosis, low cost, ability to sample without tissue injury, and ability to repeatedly sample. Disadvantages include inability to always determine tumor type or distinguish pre-invasive from invasive changes.
4. Types of cytopathology include exfoliative from spontaneously shed cells, abrasive which dislodges
Amylase and lipase are enzymes that help digest starch, glycogen, and fats. Amylase levels rise within hours of acute pancreatitis and return to normal within 3-5 days, making it useful for diagnosis. Lipase levels are more sensitive than amylase for detecting acute pancreatitis, as they remain elevated for 7-14 days. Both enzymes can also be elevated in conditions like burns, renal failure, and malignancy.
Chemical pathology involves measuring analytes in body fluids to aid in diagnosis, screening, monitoring, and prognosis of diseases. It provides over 70% of objective medical record data through tests of electrolytes, liver/kidney function markers, hormones, drugs, and tumor markers. Test results are interpreted using reference ranges which provide context for medical decisions by defining normal and abnormal values. Chemical pathology tests body fluids like blood, urine, CSF, pleural fluid, and synovial fluid to measure analytes like ions, proteins, enzymes, and organic molecules.
The document discusses 16 clinical case studies presented by Dr. Namrata Chhabra involving patients' medical histories, laboratory results, and biochemical abnormalities. For each case, Dr. Chhabra asks students to provide diagnoses based on the evidence and explain the underlying biochemical defects or mechanisms. The cases cover topics like diabetes, acid-base imbalances, enzyme deficiencies, and vitamin deficiency disorders.
Analytical and post-analytical errors can occur in clinical chemistry laboratories. Analytical errors include issues like test systems not being calibrated properly, controls being out of range but results still reported, improper measurements or reagents, and instrument maintenance issues. This can lead to inaccuracies, imprecisions, insensitivities, and linearity problems. Post-analytical errors involve things like transcription mistakes in reporting results, reports going to the wrong location, illegible reports, or reports not being sent at all. Laboratories should develop systematic workflows, continuously monitor for errors, and strengthen defenses to minimize vulnerabilities and their impacts, which can include inadequate patient care, misdiagnosis, harm, or even death.
This document discusses quality control in pathology, with a focus on histopathology. It defines key terms like quality control, quality assurance, and defines the goals of a quality system. It outlines the quality assurance cycle and different factors that can influence quality, including pre-analytical, analytical, and post-analytical phases. Specific areas of quality control in histopathology are discussed, including sample collection and handling, tissue processing, section cutting, and staining. Maintaining standards and addressing errors at each step of the histopathology process is important for accurate diagnosis.
Venous blood collection, or venipuncture, allows for collection of large blood volumes from the median cubital vein in the antecubital fossa for numerous clinical tests. The procedure involves cleaning the site, applying a tourniquet, inserting a vacutainer needle to fill test tubes, removing the needle and applying pressure to stop bleeding. Proper collection permits complete blood counts, cell analyses, and other tests to aid clinical evaluation and diagnosis.
This document provides an overview of gastric analysis, which quantifies gastric acid production by the stomach. It discusses the anatomy and physiology of the stomach and acid secretion. Methods for collecting gastric juice samples via nasogastric tube are described, including basal acid output measurement and stimulation with pentagastrin to measure peak acid output. Normal ranges for acidity measurements and their indications are provided. The document outlines contraindications and alternative tests like Hollander's test and fractional test meal.
The document discusses various pre-analytical and post-analytical errors that can occur in clinical laboratories. It notes that errors commonly occur in specimen receiving, sampling, transport, and results reporting. Some common errors include entering the wrong patient data, incomplete patient information, misidentifying tests, collecting samples from patients with the wrong test orders, and not fulfilling all requested investigations. The document also discusses various biological and environmental factors that can influence laboratory test results, such as patient posture, exercise, underlying medical conditions, drug use, and diet. Proper specimen collection and handling is important to avoid pre-analytical errors.
The peritoneal fluid analysis helps diagnose the cause of fluid accumulation in the abdominal cavity. The fluid is either a transudate or exudate based on initial tests of albumin level and cell count. A transudate is usually caused by heart or liver conditions, while an exudate requires further testing to identify potential infections, cancers, or other inflammatory conditions as the cause. Additional tests of the exudate fluid include microscopic analysis of cell types, chemical tests for glucose or tumor markers, and cultures to detect microorganisms. The results help determine whether the fluid accumulation is due to an infection, malignancy, or other disease.
This document discusses laboratory errors in medical practice. It notes that 0.1-3% of laboratory tests have errors, with most occurring in the pre-analytic and post-analytic phases rather than the analytic phase. Common pre-analytic errors include inappropriate test requests, order entry mistakes, misidentification of patients, and improper sample collection, transport, or storage. Analytic errors are less than 10% of total errors. The document also provides examples of how biological and behavioral factors can influence test results, and discusses clinical performance characteristics of medical tests.
This document discusses external quality assurance (EQA) of serological testing. It outlines key elements of a quality system including documentation, training, assessment, and standards. EQA involves laboratories testing unknown samples provided by an EQA scheme and comparing results to improve accuracy. Participating in EQA allows laboratories to identify any issues, enhance performance, and ensure quality standards are met through objective review of results across laboratories. EQA schemes provide benefits for laboratories and regulatory authorities by establishing networks to improve testing practices and public confidence in testing standards.
This chapter is largely about the water and electrolytes ( salts )in your plasma and how the body manages to keep you from drying up and blowing away even if you are in the hot Texas sun and without liquid drink.
This document discusses the uses and types of clinical biochemistry investigations as well as quality control procedures. It notes that lab tests are used to confirm diagnoses, start treatment, screen for risk, monitor disease progression and response to therapy. Tests can be emergency, routine, special, or panels focusing on specific organs or metabolic processes. Quality control ensures accuracy, precision and error-free reporting through procedures like internal controls, reference ranges, and external quality assessments. Factors like specimen collection, transport, drugs, and physiology can influence test results.
This document provides an overview of the analysis of various body fluids, including pleural, pericardial, peritoneal, synovial, and ascitic fluids. It discusses the sample collection, gross inspection, and microscopic analysis of these fluids. Key points covered include diagnostic tests for identifying conditions like pleurisy, pericarditis, tuberculous peritonitis, gout, and arthritis. Procedures like thoracentesis, paracentesis, arthrocentesis, and pericardiocentesis used to collect fluid samples are also outlined. The learning objectives are to recall sample collection and analysis of these body fluids and become familiar with related chemical, immunological, microbiological and functional tests.
Biochemistry is a basic science which deals with chemical nature and chemical behaviour of living matter and with the reactions and processes they undergo.
Biochemistry involves the study of:
Chemical constituents of living matter.
Chemical changes which occur in the organism during digestion, absorption and excretion.
Chemical changes which occur during growth and multiplication of the organism.
Transformation of one form of chemical constituent to the other.
Energy changes involved in such transformation.
Note:- The term “Biochemistry” was first introduced by German chemist Carl Neuberg in 1903 from Greek word “bios” means “life”.
It is mainly deals with the biochemical aspects that are involved in several conditions.
The results of qualitative and quantitative analysis of body fluids assist the clinicians in the diagnosis, treatment and prevention of the disease and drug monitoring, tissue and organ transplantation, forensic investigations and so on.
Various biological fluids subjected to chemical tests and assays include blood, plasma, serum, urine, cerebrospinal fluid (CSF), ascetic fluid, pleural fluid, faeces, calculi and tissues.
Note:- Modern day medical practice is highly dependent on the laboratory analysis of body fluids, especially the blood. The disease manifestations are reflected in the composition of blood and other tissues.
Hence, the demarcation of abnormal from normal constituents of the body is another aim of the study of clinical biochemistry.
This document summarizes renal clearance tests used to assess kidney function. It discusses how the kidneys maintain homeostasis, excrete waste, and produce hormones. Glomerular filtration rate is normally 120-125 mL/min, with over 99% of the filtrate reabsorbed. Clearance tests measure the rate of filtration for substances like creatinine and urea. Creatinine clearance is the most sensitive test of glomerular function, as creatinine is freely filtered and only marginally secreted. The normal creatinine clearance rate is 120-145 mL/min. A decreased clearance below 75% normal indicates impaired kidney function.
This document provides information about urinalysis, including specimen collection, types of analysis, and microscopic examination. Specimens should be first morning void and analyzed within 2 hours of collection. Types of analysis include macroscopic examination of color, odor, and turbidity; chemical analysis using urine dipstick for glucose, bilirubin, ketones, specific gravity, blood, pH, protein, urobilinogen, nitrite, and leukocyte esterase; and microscopic examination of cells, casts, crystals, and microorganisms. Abnormal findings on microscopic examination include increased red and white blood cells, epithelial cells, bacteria, fungi, and pathological crystals.
Pre analytic and postanalytic test managementVarsha Shahane
The document discusses principles of pre-analytic, analytic, and post-analytic test management. It covers test selection and evaluation, requisition and test menu formats, and report formatting. The three phases of quality assurance - pre-analytic, analytic, and post-analytic - are described in detail, including factors influencing each phase like specimen handling, equipment calibration, and report review. Quality control procedures are also outlined to ensure test accuracy and reproducibility.
diagnostic Cytology introduction , Body fluids cytologyAayra
This document discusses diagnostic cytopathology. It covers:
1. Cytopathology examines cells from body cavities, mucosal surfaces, and organs/masses obtained via needle aspiration to determine the cause of disease microscopically.
2. The history of cytopathology including the contributions of Papanicolaou and Koss.
3. The advantages of cytopathology include rapid diagnosis, low cost, ability to sample without tissue injury, and ability to repeatedly sample. Disadvantages include inability to always determine tumor type or distinguish pre-invasive from invasive changes.
4. Types of cytopathology include exfoliative from spontaneously shed cells, abrasive which dislodges
Amylase and lipase are enzymes that help digest starch, glycogen, and fats. Amylase levels rise within hours of acute pancreatitis and return to normal within 3-5 days, making it useful for diagnosis. Lipase levels are more sensitive than amylase for detecting acute pancreatitis, as they remain elevated for 7-14 days. Both enzymes can also be elevated in conditions like burns, renal failure, and malignancy.
Chemical pathology involves measuring analytes in body fluids to aid in diagnosis, screening, monitoring, and prognosis of diseases. It provides over 70% of objective medical record data through tests of electrolytes, liver/kidney function markers, hormones, drugs, and tumor markers. Test results are interpreted using reference ranges which provide context for medical decisions by defining normal and abnormal values. Chemical pathology tests body fluids like blood, urine, CSF, pleural fluid, and synovial fluid to measure analytes like ions, proteins, enzymes, and organic molecules.
The document discusses 16 clinical case studies presented by Dr. Namrata Chhabra involving patients' medical histories, laboratory results, and biochemical abnormalities. For each case, Dr. Chhabra asks students to provide diagnoses based on the evidence and explain the underlying biochemical defects or mechanisms. The cases cover topics like diabetes, acid-base imbalances, enzyme deficiencies, and vitamin deficiency disorders.
POCT is clinical laboratory testing conducted close to the site of patient care where care or treatment is provided.
It provides rapid turnaround of test results with the potential to generate a result quickly so that appropriate treatment can be implemented, leading to improved clinical or economic outcomes compared to laboratory testing.
Identify appropriate indications for point-of-care testing based on patient presentation and clinical scenario.
Apply quality control measures and perform regular maintenance and calibration of point-of-care testing equipment to ensure accurate and reliable results.
Implement point-of-care testing procedures following established protocols, including proper specimen collection, handling, and storage.
Collaborate with other healthcare professionals in the interpretation and integration of point-of-care test results into patient management plans.
This document summarizes information about sepsis in surgical patients, biomarkers for sepsis detection, and the Surviving Sepsis Campaign 2021 guidelines. It discusses definitions of sepsis, SIRS criteria, qSOFA and SOFA scores. Key points include the importance of early source control, the role of lactate and C-reactive protein as biomarkers, and the need for a multidisciplinary approach involving surgeons, infectious disease specialists and others to determine the best source control strategy for each patient.
This document discusses therapeutic drug monitoring (TDM), including its definition, introduction, criteria for when it is useful/unnecessary, and process. TDM involves measuring drug concentrations in blood/plasma to help adjust dosages to a desired therapeutic range. It is especially useful for drugs with a narrow therapeutic index or large interindividual variability. The TDM process involves collecting a biological sample at steady state, requesting a lab analysis, the lab measuring the drug level using an appropriate analytical technique, communicating the results along with the therapeutic range, and the clinician interpreting the level based on dosage and patient factors. Commonly monitored drugs and some problems with TDM services are also mentioned.
This document provides an overview of experimental epidemiology. It begins with the introduction and history of randomized controlled trials (RCTs) including some of the earliest planned trials in the 15th and 18th centuries. It then describes the typical steps in an RCT: drawing up a protocol, selecting and randomizing populations, implementing interventions, follow up, and assessing outcomes. Next, it discusses types of RCTs including clinical, preventive, risk factor, and health services trials. The remainder of the document outlines threats to internal validity like history, maturation, testing, and placebo effects that can undermine the conclusions of an experimental study.
This document discusses Phase 1 clinical trials. Phase 1 trials involve small studies (20-80 subjects) to determine the safety and tolerability of new drugs in healthy volunteers. They aim to determine the maximum tolerated dose and identify any side effects. The document outlines the objectives, study designs, populations and endpoints of Phase 1 trials. It provides guidance on determining starting doses based on preclinical toxicology studies in animals and safety factors. It also discusses assessments required for special populations and potential drug interactions.
JOURNAL about long term lithium treatments in elderly patients with mild cogn...anintamelie
The document describes a randomized clinical trial that investigated the effects of long-term low-dose lithium treatment in older adults with amnestic mild cognitive impairment. 61 participants were randomly assigned to receive either lithium or placebo treatment for 2 years, followed by a 2-year extension phase without blinding. The primary outcomes were changes in cognitive and functional scores after 2 years. Secondary outcomes included neuropsychological tests, CSF biomarkers, and conversion to dementia. Results showed that the lithium and placebo groups were similar at baseline on sociodemographic, clinical, and biological measures.
Role of toxicological analysis in clinical practicalPh F. Al-t
Analytical toxicology plays an important role in clinical practice by aiding in the diagnosis and treatment of toxic exposures. It is useful for identifying the toxic substance and measuring the amount absorbed, which can help clinicians relate symptoms to effects. Toxicology laboratories also monitor chemical levels remaining in the body and being excreted to assess treatment effectiveness. Examples given were measuring acetaminophen, salicylate, alcohol, and glycol levels to evaluate overdoses and prognosis. The general clinical strategy for treating poisoned patients includes stabilization, prevention of further absorption, enhancing elimination, antidote administration if available, and supportive care.
Assignment on Toxicokinetics- Toxicokinetic evaluation in preclinical studies, saturation kinetics Importance and applications of toxicokinetic studies. Alternative methods to animal toxicity testing.
Toxicology screening and therapeutic drug monitoring (an introduction) Hossamaldin Alzawawi
Therapeutic drug monitoring (TDM) involves measuring drug concentrations in patients to optimize drug therapy and avoid toxicity. TDM emerged in the 1960s with pharmacokinetic studies linking drug levels to outcomes. Pioneers in the 1970s demonstrated that constructing therapeutic ranges could reduce adverse reactions to drugs like digoxin. TDM utilizes pharmacokinetics and pharmacodynamics to assess medication efficacy and safety. It aims to individualize treatment and tailor it to each patient's needs. Factors like genetics, disease states, and drug interactions cause vast inter-patient variability in how drugs are absorbed, distributed, and eliminated.
This document provides information about the clinical laboratory and the roles of various personnel within it. It discusses:
1) Personnel in the laboratory including pathologists, medical technologists, technicians, and assistants.
2) The use of laboratory testing to obtain diagnostic data alongside a health history and exam.
3) Certifying agencies that regulate laboratory personnel.
4) The role of the clinical laboratory in providing diagnostic tools to physicians.
This document summarizes recent developments in analyzing urine using metabolomics approaches. It discusses urine sampling methods and traditional urinalysis techniques. It then reviews recent developments using non-hyphenated and chromatographic spectrometric platforms like NMR, MS, GC, and LC for metabolite profiling and fingerprinting. Specific examples are provided on using GC-MS and HILIC-MS for urine analysis and biomarker discovery.
The document discusses the importance of preoperative evaluation and optimization of patient health before surgery. The key purposes are to document medical conditions requiring surgery, assess overall health status, uncover hidden conditions that could cause problems during or after surgery, determine perioperative risk, and develop an appropriate perioperative care plan. This involves a thorough medical history, physical exam, and laboratory tests to evaluate organ function and minimize surgical risks. The goal is to reduce postoperative complications and facilitate a quick recovery.
Clinical trials are conducted in phases to evaluate a drug's safety, efficacy, and appropriate dosage before full approval. Phase 0 involves micro-dosing a small number of subjects to evaluate pharmacokinetics and select candidates for further study. Phase I studies first administer a drug to healthy volunteers to determine safety and tolerable dosage. Phase II explores efficacy and optimal dosage in patients, while Phase III involves hundreds to thousands of patients to confirm efficacy and monitor long-term safety. Each phase helps inform the next and determine if development should continue.
Biochemical tests in clinical medicine lect1MUDASSAR ANWER
This document discusses biochemical tests in clinical medicine. It covers topics such as the role of clinical biochemistry laboratories in disease diagnosis and treatment monitoring, common analyses performed, and diseases investigated using these tests. It also addresses the uses of biochemical tests in diagnosis, screening, prognosis, and treatment, as well as factors that can affect test results and their interpretation.
Lab Results Interpretation for Pharmacist A.NouriAhmed Nouri
PHARMACISTS dealing with LAB RESULTS reading, each pharmacist needs to have the basic knowledge regarding lab results and how to deal with it . Ahmed Nouri, PharmD
Similar to _CHEMICAL PATHOLOGY`Intro 2022.pptx (20)
Nucleophilic Addition of carbonyl compounds.pptxSSR02
Nucleophilic addition is the most important reaction of carbonyls. Not just aldehydes and ketones, but also carboxylic acid derivatives in general.
Carbonyls undergo addition reactions with a large range of nucleophiles.
Comparing the relative basicity of the nucleophile and the product is extremely helpful in determining how reversible the addition reaction is. Reactions with Grignards and hydrides are irreversible. Reactions with weak bases like halides and carboxylates generally don’t happen.
Electronic effects (inductive effects, electron donation) have a large impact on reactivity.
Large groups adjacent to the carbonyl will slow the rate of reaction.
Neutral nucleophiles can also add to carbonyls, although their additions are generally slower and more reversible. Acid catalysis is sometimes employed to increase the rate of addition.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Phenomics assisted breeding in crop improvementIshaGoswami9
As the population is increasing and will reach about 9 billion upto 2050. Also due to climate change, it is difficult to meet the food requirement of such a large population. Facing the challenges presented by resource shortages, climate
change, and increasing global population, crop yield and quality need to be improved in a sustainable way over the coming decades. Genetic improvement by breeding is the best way to increase crop productivity. With the rapid progression of functional
genomics, an increasing number of crop genomes have been sequenced and dozens of genes influencing key agronomic traits have been identified. However, current genome sequence information has not been adequately exploited for understanding
the complex characteristics of multiple gene, owing to a lack of crop phenotypic data. Efficient, automatic, and accurate technologies and platforms that can capture phenotypic data that can
be linked to genomics information for crop improvement at all growth stages have become as important as genotyping. Thus,
high-throughput phenotyping has become the major bottleneck restricting crop breeding. Plant phenomics has been defined as the high-throughput, accurate acquisition and analysis of multi-dimensional phenotypes
during crop growing stages at the organism level, including the cell, tissue, organ, individual plant, plot, and field levels. With the rapid development of novel sensors, imaging technology,
and analysis methods, numerous infrastructure platforms have been developed for phenotyping.
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...AbdullaAlAsif1
The pygmy halfbeak Dermogenys colletei, is known for its viviparous nature, this presents an intriguing case of relatively low fecundity, raising questions about potential compensatory reproductive strategies employed by this species. Our study delves into the examination of fecundity and the Gonadosomatic Index (GSI) in the Pygmy Halfbeak, D. colletei (Meisner, 2001), an intriguing viviparous fish indigenous to Sarawak, Borneo. We hypothesize that the Pygmy halfbeak, D. colletei, may exhibit unique reproductive adaptations to offset its low fecundity, thus enhancing its survival and fitness. To address this, we conducted a comprehensive study utilizing 28 mature female specimens of D. colletei, carefully measuring fecundity and GSI to shed light on the reproductive adaptations of this species. Our findings reveal that D. colletei indeed exhibits low fecundity, with a mean of 16.76 ± 2.01, and a mean GSI of 12.83 ± 1.27, providing crucial insights into the reproductive mechanisms at play in this species. These results underscore the existence of unique reproductive strategies in D. colletei, enabling its adaptation and persistence in Borneo's diverse aquatic ecosystems, and call for further ecological research to elucidate these mechanisms. This study lends to a better understanding of viviparous fish in Borneo and contributes to the broader field of aquatic ecology, enhancing our knowledge of species adaptations to unique ecological challenges.
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skills
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxMAGOTI ERNEST
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
ESPP presentation to EU Waste Water Network, 4th June 2024 “EU policies driving nutrient removal and recycling
and the revised UWWTD (Urban Waste Water Treatment Directive)”
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
3. • WHA
TISCHEMICALPA
THOLOGY?
• Chemical Pathology is the branch of pathology
dealing with the biochemical basis of disease and
the use of biochemical tests for diagnosis and
management.
• It is also known as Clinical Biochemistry or Clinical
Chemistry
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 3
6. THEUSEOFCLINICALBIOCHEMISTRYTESTS
• Laboratory tests are most often requested for
defined diagnostic purposes.
• The justification for discretionary testing is well
summarised by answering the following questions:
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 6
7. HOWOFTENSHOULDAPA
TIENTBEINVESTIGA
TED?
This depends on the following:
• How quickly numerically significant
changes are likely to occur:
• for example, concentrations of the
main plasma protein fractions are
unlikely to change significantly in less
than a week
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 7
8. HOWOFTENSHOULDAPA
TIENTBEINVESTIGA
TED?
• Whether a change, even if numerically
significant, will alter treatment:
• for example, plasma transaminase activities
may alter within 24 h in the course of acute
hepatitis, but, once the diagnosis has been
made, this is unlikely to affect treatment.
• By contrast, plasma potassium concentrations
may alter rapidly in patients given large doses
of diuretics and these alterations may indicate
the need to change treatment
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 8
11. PURPOSESOFLABORA
TORYTESTS
SCREENING
Lab tests are used for mass screening (e.g.,
phenylketonuria and sickle cell in newborns),
screening asymptomatic patients (e.g.,
mammography), and
screening symptomatic patients (e.g., stress
electrocardiogram in a patient with chest pain).
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 11
12. PURPOSESOFLABORA
TORYTESTScont’d
DIAGNOSIS
• They are used to confirm a diagnosis (e.g.,
coronary angiogram to confirm coronary artery
disease in a patient with a positive stress
electrocardiogram).
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 12
13. PURPOSESOFLABORA
TORYTESTScont’d
MONITORINGTREA
TMENT
• They are used to monitor a patient's disease status
(e.g., serum glucose in a person with uncontrolled
diabetes).
PROGNOSIS
• providing information on disease susceptibility.
e.g. prognosis can be predicted by noting the
degree of test abnormality
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 13
14. Test selection for the purpose of discretionary testing
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 14
15. LABORA
TORYSCREENINGCRITERIA
1. There must be a high prevalence of the disease to
justify the expense.
2. Significant morbidity and mortality must be
associated with the disease if it is left untreated.
3. The disease must be detectable before symptoms
surface in the patient.
4. An effective therapy must be available that is safe
and inexpensive.
5. The test must be cost effective and easily
performed in the laboratory.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 15
16. SEQUENCEOFTESTS
• Depends on several factors
1. Situation critical: test with the highest yield is
done, even though there may be some risks
2. If there is time: lower yield, less risky procedure
done first
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 16
17. ORDEROFTESTING
1. From cheap to costly
2. From less to more risky
3. From simple to more complex
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 17
18. ORDEROFTESTINGcont’d
Not always practical.
• One or more objectives may be sacrificed for
speed, convenience, accuracy, a waiting list for
procedures, time needed to await the results, and
the condition of the patient.
• Sometimes it may be best to get the costly test
done first; it may solve the problem quickly and
save money in the long run.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 18
20. What are the indicators of test reliability?
• Accuracy, Precision, Specificity and Sensitivity
• Accuracy and precision reflect how well the test
method performs day to day in a laboratory.
• Sensitivity and specificity deal with how well the
test is able to distinguish disease from absence of
disease.
• These are effectively analytical sources of
variation.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 20
21. PRECISIONANDACCURACYIN
BIOCHEMICALTESTS
• Precision: The amount of variation in results after
measuring the same sample repeatedly.
• A test method is said to be precise when repeated
analyses on the same sample give similar results.
• Accuracy: How close the result is to the "true" value as
determined by a reference method.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 21
24. • Although a test that is 100% accurate and 100%
precise is ideal, in practice, test methodology,
instrumentation, and laboratory operations all
contribute to small but measurable variations in
results.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 24
25. BIOLOGICALCAUSESOFV
ARIA
TION
• As well as analytical variation, test results also
show biological variation in both health and
disease.
• Key questions are:
• How do results vary in health?
• How do results vary in disease?
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 25
26. How do results vary in health?
• The concentrations of all analytes in blood vary
with time due to diverse physiological factors
within the individual.
• There are also differences between individuals.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 26
27. Within-individual variation
• The following may be important causes of within
individual variation:
• DIET: Variations in diet can affect the results of
many tests, including serum triglyceride
• TIME OF DAY: Several plasma constituents show
diurnal variation (variation with the time of day),
or a sleep/wake cycle. Example is cortisol
• POSTURE: Proteins and all protein-bound
constituents of plasma show significant
differences in concentration between blood
collected from upright individuals and blood from
recumbent individuals.
11-Jan-22 INTRODUCTIONTOCHEMICALPA
THOLOGY 27
28. Within-individual variation cont’d
• MUSCULAR EXERCISE: Recent exercise, especially
if vigorous or unaccustomed, may increase serum
creatine kinase (CK) activity in blood [lactate],
and lower blood [pyruvate].
• MENSTRUALCYCLE: Several substances show
variation with the phase of the cycle. Examples
include serum [iron], and the serum
concentrations of the pituitary gonadotrophins
• DRUGS: These can have marked effects on
chemical results.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 28
29. RESUL
TSV
ARIA
TION
SERUM CREATININE [umol/L] IN FOUR APPARENTLY
HEALTHY INDIVIDUALS IN SIX SAMPLES TAKEN AT DAILY
INTERVALS
Sample Subject 1 Subject 2 Subject 3 Subject 4
1 86 124 97 144
2 81 128 93 139
3 82 120 95 141
4 84 126 91 138
5 80 130 97 146
6
11-Jan-22
85 128 91
INTRODUCTION TOCHEMICALP
A
THOLOGY
144 29
31. Between-individual variation
• Differences between individuals can affect the
concentrations of analytes in the blood. The
following are the main examples:
• AGE: Examples include serum [phosphate] and
alkaline phosphatase (ALP) activity
• SEX: Examples include serum creatinine, iron,
urate and urea concentrations
• RACE: Racial differences have been described for
serum [cholesterol] and [protein].
It may be difficult to distinguish racial from
environmental factors, such as diet
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 31
32. How do results vary in disease?
• Biochemical test results do not exist in isolation.
• For example, in a patient with severe abdominal
pain, tenderness and rigidity, there may be several
differential diagnoses to consider – including, for
example,
• acute pancreatitis
• perforated peptic ulcer and
• acute cholecystitis.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 32
33. ANAL
YTICALSENSITIVITYAND
SPECIFICITY
• The analytical sensitivity of an assay is a
measure of how little of the analyte the
method can detect.
• The assay’s ability to detect very low
concentrations of a given substance in a
biological specimen.
• Analytical sensitivity is often referred to as
the limit of detection (LoD).
• LoD is the actual concentration of an analyte
in a specimen that can be consistently
detected ≥ 95% of the time.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 33
34. ANAL
YTICALSPECIFICITY
• Analytical specificity of an assay relates to how
good the assay is at discriminating between the
requested analyte and potentially interfering
substances.
• The assay’s ability to detect the intended target.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 34
35. REFERENCERANGES
• Reference intervals/ ranges are fundamental tools
used by medical practitioners to interpret patient
laboratory test results and help differentiate
between healthy and unhealthy individuals.
• Also referred to as “normal” or “expected” values,
reference intervals provide the range of
laboratory test results that would be expected in
a healthy population.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 35
36. REFERENCERANGEScont’d
• Results are therefore interpreted by comparing
with a set of results from a particular defined (or
reference) population.
• To interpret results on patients adequately, we
need to know:
• the reference range for healthy individuals of the
appropriate age range and of the same sex;
• the values to be expected for patients with the
disease, or diseases, under consideration
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 36
37. REFERENCERANGEScont’d
• Biochemical test results are usually compared
to a reference interval chosen arbitrarily to
include 95% of the values found in healthy
volunteers.
• This means that, by definition, 5% of any
population will have a result outside the
reference interval
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 37
42. • Diagnostic/Test Sensitivity
• Sensitivity is the ability of a test to correctly
identify individuals who have a given disease or
condition.
• For example, a certain test may have proven to be
90% sensitive
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 42
43. • Diagnostic/Test Specificity
• Specificity is the ability of a test to correctly
exclude individuals who do not have a given
disease or condition.
• For example, a certain test may have proven to be
90% specific
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 43
44. • sensitivity (the ability of a test to detect a disease
when it is present), and specificity ( the ability of a
test to reflect the absence of the disease in those
disease-free) can be calculated as follows:
• Specificity= 100 x TN / (TN + FP) %
• Sensitivity = 100 x TP / (TP + FN) %
• Where,
• TN=True negative
• TP= True positive
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 44
47. • In Fig above, both graphs show the distribution of
results for repeated analysis of the same sample by
different methods.
• Methods A and B on the left are equally accurate (mean
value is the same) but the lesser scatter in A makes it
more precise.
• C and D on the right are equally precise, but in D the
mean value differs from the true, so C is more accurate.
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 47
50. CASESTUDY
• A sample from a 65-year-old male arrived in the
laboratory at 9 am from a well-man clinic. The
potassium is 8.5 mmol/L which is dangerously high.
The sample is repeated and the same result is
obtained. All other laboratory checks have been
carried out and the result is analytically valid. The
result is telephoned to the GP who reveals that the
sample was taken at 4 pm the previous day by the
nurse.
(a) What is the most likely cause of the high result?
(b) What would your recommended course of action
be?
11-Jan-22 INTRODUCTIONTOCHEMICALP
A
THOLOGY 50